share_log

Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

SEC ·  Nov 13 20:43
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.